For patients living with chronic migraine, the effectiveness of preventive treatment often depends on precision—not just in the dose, but in the timing. A novel retrospective study from a specialized headache clinic in Spain suggests that integrating advanced practice nurses (APNs) into the care team significantly improves a patient’s ability to stay on schedule with these critical injections.
The study focused on patients receiving onabotulinumtoxinA, a preventive treatment for chronic migraine. Specifically, researchers tracked adherence to the PREEMPT protocol, which recommends a specific window for consecutive injections to maintain therapeutic stability. In a real-world clinical setting, maintaining this schedule can be difficult due to staffing constraints and scheduling conflicts.
Analyzing data from 2,991 participants—the majority of whom were women with a median age of 48—the researchers compared three 18-month periods. The first period relied solely on neurologists for administration; the subsequent two periods introduced advanced practice nurses into the workflow.
The Impact of Consistent Scheduling
Under the PREEMPT protocol, treatment is considered “interval-compliant” if the time between injections falls between 75 and 105 days. When neurologists managed the injections alone, only 52.1% of patients remained within this window.
Once APNs were introduced, adherence jumped to 76.1% and remained stable across the following periods. The timing also became more consistent; the median interval between visits dropped from 105 days in the first period to 96 days in the second and 98 days in the third.
This shift suggests that the presence of APNs helps prevent the “treatment drift” that often occurs in busy outpatient clinics, ensuring patients receive their prophylaxis before the effects of the previous dose wear off.
Clinical Context: The PREEMPT Protocol
The Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) program established the efficacy and safety of onabotulinumtoxinA (BOTOX®) for chronic migraine. The protocol provides a standardized framework for injection sites and timing to ensure the most predictable preventive outcome for patients.
More Than Just Extra Hands
The researchers noted that the improvement in adherence likely stemmed from more than just increased staffing capacity. The introduction of APNs appeared to enhance the overall patient experience through better communication, easier access to the clinic, and more efficient management of the appointment calendar.
By handling the administration and scheduling of onabotulinumtoxinA, APNs may reduce the clinical burden on neurologists, allowing them to focus on complex diagnostic operate while ensuring the patient’s routine preventive care remains uninterrupted.
Maintaining this continuity is essential for stable migraine control, as inconsistent dosing can lead to a return of symptoms or a loss of treatment efficacy.
But, the study carries important caveats. Because this was a single-center retrospective analysis, the results may not apply to every clinical environment. The researchers used “adherence” as a surrogate outcome. They did not directly measure whether the improved timing led to a decrease in headache frequency or a reduction in the utilize of acute medications.
While the study does not prove a direct increase in clinical efficacy, it demonstrates a clear improvement in the delivery of care, suggesting that the APN model could be a viable strategy for optimizing chronic migraine pathways globally.
For healthcare systems struggling with neurologist shortages and long wait times, this model offers a potential path toward more reliable, patient-centered care.
Clinical Questions
Why is the 75-to-105-day window important?
Following the PREEMPT protocol’s timing helps ensure that the preventive effects of onabotulinumtoxinA are maintained, preventing the “gap” in coverage that can trigger a return of chronic migraine symptoms.
What is a “surrogate outcome” in this study?
A surrogate outcome is a marker (in this case, the timing of the appointment) used to predict a clinical benefit. While the study proved patients were more likely to get their shots on time, it did not measure the final clinical goal: whether the patients actually had fewer migraines.
Could the integration of specialized nursing roles similarly improve adherence for other complex, time-sensitive neurological treatments?
